Evidence map›Paper›PMID 35571803›Full record

ArticleACS omega2022

Experimental and Molecular Modeling Studies on the Complexation of Chromium(III) with the Angiotensin-Converting Enzyme Inhibitor Captopril.

Shimaa A Mahmoud, Mohamed Taha, Eman S H Khaled, Walid Hamdy Hassan, Fatma I Abo El-Ela, Ahmed A Abdel-Khalek, Reham A Mohamed

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shimaa A MahmoudChemistry Department, Faculty of Science, Beni-Suef University, 62511 Beni-Suef, Egypt.
Mohamed TahaMaterials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, 62511 Beni-Suef, Egypt.ORCID https://orcid.org/0000-0002-5367-2009
Eman S H KhaledChemistry Department, Faculty of Science, Beni-Suef University, 62511 Beni-Suef, Egypt.
Walid Hamdy HassanDepartment of Microbiology Mycology and Immunology, Faculty of Veterinary Medicine, Beni-Suef University, 62511 Beni-Suef, Egypt.
Fatma I Abo El-ElaDepartment of Pharmacology, Faculty of Veterinary Medicine, Beni-Suef University, 62511 Beni-Suef, Egypt.
Ahmed A Abdel-KhalekChemistry Department, Faculty of Science, Beni-Suef University, 62511 Beni-Suef, Egypt.
Reham A MohamedChemistry Department, Faculty of Science, Beni-Suef University, 62511 Beni-Suef, Egypt.
Beni-Suef University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Captopril (CPT) is an inhibitor of angiotensin I converting enzyme, used as a medication for the treatment of people with high blood pressure, renal insufficiency, and cardiovascular diseases. It inhibits the angiogenesis process, vasoconstriction, and tumor metastasis. Some metal-captopril complexes exhibit antimicrobial activities. In the current work, the formation of the Cr

Identifiers

PMID35571803
PMCPMC9096923
OpenAlexW4225013662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.